Evaluation of the ability of canarypox-vectored equine influenza virus vaccines to induce humoral immune responses against canine influenza viruses in dogs

American Journal of Veterinary Research

Volumn 68, Issue 2, 2007, Pages 208-212

  Karaca, Kemal ^a   Dubovi, Edward J ^c   Siger, Leonardo ^a   Robles, Amy ^a   Audonnet, Jean Christophe ^a   Jiansheng, Yao ^d   Nordgren, Robert ^b   Minke, Jules M ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b Research and Development Division   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d Sanofi Pasteur   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; INFLUENZA VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS VECTOR;

AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CANARYPOX VIRUS; CONTROLLED STUDY; CROSS REACTION; DOG; FEMALE; HEMAGGLUTINATION INHIBITION; HUMORAL IMMUNITY; INFLUENZA VIRUS; MALE; NONHUMAN; SERUM; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; CANARYPOX VIRUS; DOG DISEASES; DOGS; FEMALE; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; MALE; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES, SYNTHETIC;

ANIMALIA; CANIS FAMILIARIS; EQUINE INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 33847676242     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.2.208     Document Type: Article

References (16)

1. Crawford PC, Dubovi EJ, Catleman WL, et al. Transmission of equine influenza virus to dogs. Science 2005;310:482-485.
2. Yoon K-J, Cooper VL, Schwartz, KJ, et al. Influenza virus infection in racing greyhounds. Emerg Infect Dis 2005;11:1974-1975.
3. Animal Health Diagnostic Center - Emerging Issues, Diagnostic Lab Web site, Department of Population Medicine & Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY. Available at: diaglab.vet.cornell.edu/issues/civ-stat.asp. Accessed Aug 14, 2006.
4. Minke JM, Siger L, Karaca K, et al. Recombinant canarypox virus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch Virol Suppl 2004;18:221-230.
5. Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999;37:937-943.
6. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
7. Couch RB, Kasel JA. Immunity to influenza in man. Ann Rev Immunol 1983;37:529-549.
8. Murphy BR, Clements ML. The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microb Immunomol 1989;146:107-116.
9. Belshe RB, Gruber WC, Mendelman PM, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis 2000;181:1133-1137.
10. Rennels MB, Meissner CH, Committee on Infectious Diseases. Technical report: reduction of the influenza burden in children. Pediatrics 2002;110:1-18.
11. Newton JR, Daly JM, Spencer L, et al. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet Rec 2006;158:185-192.
12. Toulemonde CE, Daly J, Sindle T, et al. Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet Rec 2005;156:367-371.
13. Paillot R, Kydd JH, Sindle T, et al. Antibody and IFN-γ responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus. Vet Immunol Immunopathol 2006;112:225-233.
14. Belshe RB, Frances K, Newman FK, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004;351:2286-2294.
15. Jackson LA, Austin G, Chen RT, et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine 2001;19:4703-4709.
16. Wesley RD, Lager KM. Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus. Am J Vet Res 2005;66:1943-1947.